Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells
-
- Takakura Hideki
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University
-
- Horinaka Mano
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine
-
- Imai Ayaka
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine
-
- Aono Yuichi
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Department of Biomedical Chemistry, Kwansei Gakuin University
-
- Nakao Toshimasa
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine
-
- Miyamoto Shingo
- Epidemiology and Prevention Division, Center for Public Health Sciences, National Cancer Center
-
- Iizumi Yosuke
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine
-
- Watanabe Motoki
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine
-
- Narita Takumi
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine
-
- Ishikawa Hideki
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine
-
- Mutoh Michihiro
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Epidemiology and Prevention Division, Center for Public Health Sciences, National Cancer Center
-
- Sakai Toshiyuki
- Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine
Search this article
Description
<p>As colon cancer is one of the most common cancers in the world, practical prevention strategies for colon cancer are needed. Recently, treatment with aspirin and/or 5-aminosalicylic acid-related agents was reported to reduce the number of intestinal polyps in patients with familial adenomatous polyposis. To evaluate the mechanism of aspirin and 5-aminosalicylic acid for suppressing the colon polyp growth, single and combined effects of 5-aminosalicylic acid and sodium salicylate (metabolite of aspirin) were tested in the two human colon cancer cells with different cyclooxygenase-2 expression levels and intestinal polyp-derived cells from familial adenomatous polyposis model mouse. The combination induced cell-cycle arrest at the G1 phase along with inhibition of cell growth and colony-forming ability in these cells. The combination reduced cyclin D1 via proteasomal degradation and activated retinoblastoma protein. The combination inhibited the colony-forming ability of mouse colonic mucosa cells by about 50% and the colony-forming ability of mouse intestinal polyp-derived cells by about 90%. The expression level of cyclin D1 in colon mucosa cells was lower than that in intestinal polyp-derived cells. These results suggest that this combination may be more effective in inhibiting cell growth of intestinal polyps through cyclin D1 down-regulation.</p>
Journal
-
- Journal of Clinical Biochemistry and Nutrition
-
Journal of Clinical Biochemistry and Nutrition 70 (2), 93-102, 2022
SOCIETY FOR FREE RADICAL RESEARCH JAPAN